Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

  2. Share Prices
  3. Astrazeneca Share Price
  4. Astrazeneca Share News
  5. UK BROKER RATINGS SUMMARY: Goldman Downgrades Melrose And Aston Martin

Pin to quick picksAstrazeneca Share News (AZN)

Astrazeneca Information

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Goldman Downgrades Melrose And Aston Martin

Mon, 27th Apr 2020 10:23

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

----------

FTSE 100

----------

GOLDMAN SACHS CUTS MELROSE INDUSTRIES TO 'NEUTRAL' ('BUY') - TARGET 100 (130) PENCE

----------

JEFFERIES CUTS ANGLO AMERICAN PRICE TARGET TO 1700 (1750) PENCE - 'BUY'

----------

JEFFERIES CUTS GLENCORE TO 'HOLD' (BUY) - PRICE TARGET 150 (175) PENCE

----------

CITIGROUP CUTS FLUTTER TO 'SELL' ('NEUTRAL') - TARGET 7200 (5508) PENCE

----------

CITIGROUP CUTS INTERCONTINENTAL HOTELS PRICE TARGET TO 2750 (2800) P - 'SELL'

----------

ODDO BHF RAISES DIAGEO TO 'BUY' ('NEUTRAL') - PRICE TARGET 3130 (2480) PENCE

----------

DEUTSCHE BANK CUTS WHITBREAD PRICE TARGET TO 2690 (3340) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS PEARSON PRICE TARGET TO 450 (500) PENCE - 'HOLD'

----------

MORGAN STANLEY RAISES BAE SYSTEMS TO 'OVERWEIGHT' ('EQUAL-WEIGHT') - TARGET 625 (685) PENCE

----------

HSBC CUTS COMPASS GROUP PRICE TARGET TO 1410 (1915) PENCE - 'HOLD'

----------

BARCLAYS RAISES ASTRAZENECA PRICE TARGET TO 9000 (8000) PENCE - 'OVERWEIGHT'

----------

FTSE 250

----------

GOLDMAN SACHS CUTS ASTON MARTIN LAGONDA TO 'SELL' - TARGET 40 (125) PENCE

----------

DEUTSCHE BANK REINITIATES ASTON MARTIN WITH 'HOLD' - PRICE TARGET 45 PENCE

----------

MORGAN STANLEY CUTS WOOD GROUP PRICE TARGET TO 250 (280) PENCE - 'OVERWEIGHT'

----------

CITIGROUP RAISES WILLIAM HILL PRICE TARGET TO 130 (124) PENCE - 'BUY'

----------

LIBERUM RAISES IG GROUP PRICE TARGET TO 740 (725) PENCE - 'HOLD'

----------

RBC CUTS MITCHELLS & BUTLERS PRICE TARGET TO 175 (450) PENCE - 'SECTOR PERFORM'

----------

RBC CUTS MARSTONS PRICE TARGET TO 40 (130) PENCE - 'SECTOR PERFORM'

----------

RBC CUTS JD WETHERSPOON PRICE TARGET TO 800 (1550) PENCE - 'UNDERPERFORM'

----------

BARCLAYS RESUMES IG GROUP WITH 'OVERWEIGHT' - TARGET 860 PENCE

----------

RBC CUTS DUNELM GROUP TO 'SECTOR PERFORM' (OUTPERFORM) - PRICE TARGET 950 (900) PENCE

----------

JEFFERIES CUTS CLOSE BROTHERS TO 'UNDERPERFORM' ('HOLD') - TARGET 800 (1410) P

----------

JPMORGAN RAISES SPECTRIS PRICE TARGET TO 2350 (2175) PENCE - 'NEUTRAL'

----------

OTHER MAIN MARKET AND AIM

----------

JEFFERIES CUTS SOUTH32 PRICE TARGET TO 80 (90) PENCE - 'HOLD'

----------

LIBERUM RESUMES HALFORDS GROUP WITH 'BUY' - TARGET 200 PENCE

----------

RBC CUTS RESTAURANT GROUP PRICE TARGET TO 70 (90) PENCE - 'SECTOR PERFORM'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
12345678910

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.